De novo donor‐specific HLA antibodies after combined intestinal and vascularized composite allotransplantation — a retrospective study

De novo donor‐specific HLA antibodies after combined intestinal and vascularized composite allotransplantation — a retrospective study

Combining vascularized composite allotransplantation (VCA) with intestinal transplantation to achieve primary abdominal closure has become a feasible procedure. Besides facilitating closure, the abdominal wall can be used to monitor intestinal rejection. As the inclusion of a VCA raises the possibil...

Bibliográfalaš dieđut
Váldodahkkit:	Weissenbacher, A, Vrakas, G, Chen, M, Reddy, S, Allan, P, Giele, H, Barnardo, M, Vaidya, A, Friend, P, Fuggle, S
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Wiley 2017

Geahča maid

Meeting report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation
Dahkki: Weissenbacher, A, et al.
Almmustuhtton: (2018)

The deceased donor score system as tool to guide preservation strategies before organ recovery and HLA-match
Dahkki: Plata-Munoz, J, et al.
Almmustuhtton: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
Dahkki: Plata-Munoz, J, et al.
Almmustuhtton: (2009)

The impact of intestinal transplantation on quality of life
Dahkki: Ambrose, T, et al.
Almmustuhtton: (2019)

Preclinical Studies in Vascularized Composite Allotransplantation
Dahkki: Andreea Grosu-Bularda, et al.
Almmustuhtton: (2023-03-01)

Perfusion decellularization for vascularized composite allotransplantation
Dahkki: Danielle L Nicholls, et al.
Almmustuhtton: (2022-09-01)

Cell therapy in vascularized composite allotransplantation
Dahkki: Madonna Rica Anggelia, et al.
Almmustuhtton: (2022-06-01)

Patient Advocacy in Vascularized Composite Allotransplantation
Dahkki: James Benedict
Almmustuhtton: (2022-07-01)

Sensitization and Desensitization in Vascularized Composite Allotransplantation
Dahkki: Dimitrios Moris, et al.
Almmustuhtton: (2021-08-01)

Costimulation Blockade in Vascularized Composite Allotransplantation
Dahkki: Dimitrios Giannis, et al.
Almmustuhtton: (2020-09-01)

Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
Dahkki: Christina L Kaufman, et al.
Almmustuhtton: (2020-07-01)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
Dahkki: Covadonga López del Moral, et al.
Almmustuhtton: (2022-09-01)

Impact of monoclonal antibody based-induction therapy on postoperative graft function and survival of kidneys from non-heart-beating donors.
Dahkki: Plata-Munoz, J, et al.
Almmustuhtton: (2007)

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation
Dahkki: Adriana Franco-Acevedo, et al.
Almmustuhtton: (2023-04-01)

The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
Dahkki: Kadiyala V. Ravindra, et al.
Almmustuhtton: (2012-01-01)

Immunogenicity and tolerance induction in vascularized composite allotransplantation
Dahkki: Jiahui (Angela) Sun, et al.
Almmustuhtton: (2024-02-01)

Current status of vascularized composite tissue allotransplantation
Dahkki: Karoline Edtinger, et al.
Almmustuhtton: (2014-04-01)

Recellularization of Bioengineered Scaffolds for Vascular Composite Allotransplantation
Dahkki: Aisha Adil, et al.
Almmustuhtton: (2022-05-01)

A Lifesaving View of Vascularized Composite Allotransplantation
Dahkki: Katrina A Bramstedt PhD, MA
Almmustuhtton: (2018-06-01)

The deceased donor score system in kidney transplants from deceased donors after cardiac death.
Dahkki: Plata-Munoz, J, et al.
Almmustuhtton: (2010)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Dahkki: Procter, J, et al.
Almmustuhtton: (2009)

Need for Kidney Transplantation Following Vascularized Composite Allotransplantation: An International, Multi-Center Experience
Dahkki: J. Reed McGraw, BS, et al.
Almmustuhtton: (2024-01-01)

Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
Dahkki: Ravi Starzl, et al.
Almmustuhtton: (2013-01-01)

Novel Osteomyocutaneous Flap Model for Vascularized Composite Allotransplantation
Dahkki: David L. Tran, et al.
Almmustuhtton: (2024-09-01)

Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
Dahkki: Barnardo, M, et al.
Almmustuhtton: (2000)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Dahkki: Procter, J, et al.
Almmustuhtton: (2009)

Preemptive Treatment of De Novo Donor Specific Anti-HLA Antibodies With IVIG Monotherapy after Lung Transplantation
Dahkki: Jennifer K. McDermott, et al.
Almmustuhtton: (2024-09-01)

Molecular Signature Associated With Acute Rejection in Vascularized Composite Allotransplantation
Dahkki: Michael F. Cassidy, MD, et al.
Almmustuhtton: (2024-10-01)

Quantification of donor microchimerism in sex-mismatched porcine allotransplantation by competitive PCR
Dahkki: Nancy Morin, et al.
Almmustuhtton: (2004-07-01)

Successful Single Donor Islet Allotransplantation in the Streptozotocin Diabetes Rat Model
Dahkki: Henning Jahr, et al.
Almmustuhtton: (2002-09-01)

The association between HLA-DR, DQ antigens and vulvar lichen sclerosus in UK
Dahkki: Gao, X, et al.
Almmustuhtton: (2001)

Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development
Dahkki: Vadim Jucaud
Almmustuhtton: (2024-07-01)

Preservation solutions for attenuation of ischemia–reperfusion injury in vascularized composite allotransplantation
Dahkki: Shaishav Datta, et al.
Almmustuhtton: (2021-07-01)

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
Dahkki: Yur-Ren Kuo, et al.
Almmustuhtton: (2012-01-01)

Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
Dahkki: Jonas T. Schnider, et al.
Almmustuhtton: (2013-01-01)

Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation
Dahkki: Chao-Hsin Huang, et al.
Almmustuhtton: (2024-10-01)

Incorporating Trauma-informed Approaches to Care in Vascularized Composite Allotransplantation
Dahkki: Erika Thys, BA, et al.
Almmustuhtton: (2024-01-01)

Cellular activation pathways and interaction networks in vascularized composite allotransplantation
Dahkki: Leonard Knoedler, et al.
Almmustuhtton: (2023-05-01)

Ensuring Racial and Ethnic Inclusivity in Facial Vascularized Composite Allotransplantation
Dahkki: Martin Kauke-Navarro, MD, et al.
Almmustuhtton: (2023-08-01)

Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation
Dahkki: Jan A. Plock, et al.
Almmustuhtton: (2013-07-01)